SlideShare une entreprise Scribd logo
1  sur  32
Télécharger pour lire hors ligne
Pluto a new hope for resistant and intolerant patients MenattallahElserafy Mohamed Swilam Mona Elkhateib Ola Elgamal RanaKhamis
Executive Summary ,[object Object]
 Our goal is to achieve 75% of the market share within the next 5 years reaching a total of 16.6 million L.E allowing us to continue research for the patient’s welfare.  ,[object Object]
Strength Patient’s trust in Novartis. Experienced R&D employee.  Compliance due to easy route of administration (400 mg PO bid)
Cont. In comparison to Mirac: It has higher affinity. It has higher Plasma  concentration.    Tolerable side effects. Effective in Mirac intolerant patients. Effective in resistant CML.
Weakness Has side effects (hematologic and nonhematologic AEs). High monthly cost (1500 L.E)
Opportunities Patient resistance to first line treatment. Increased patient awareness about their condition. Increased physicians awarenessabout CML.
Threats Emergence of resistance. Marketed competitive drugs. Small market ( 20% of CML patients). Becoming unaffordable Late diagnosis and noncompliance to treatment due to high level of illiteracy.
Strategic objectives
Strategic objectives
STRATEGY FORMULATION Pluto Offerings
Position Pluto has high tolerance and effective against resistant CML
STRATEGY FORMULATION 2) Stakeholders
STRATEGY FORMULATION 3) Market segmentation
4) Marketing Strategy
We put our patient first Patient                               care Psychological  support Increase  Awareness of  Community about CML Make the drug  affordable for poor  patients
Psychological support  Build a bridge between CML resistant and intolerant patients and caregivers. - create a club for CML resistant and intolerant patients on CML Egypt website. (inspired by CML earth) Hug Hi five Share feelings You are not alone
Psychological support (cont.) Cancer society (NGO) Awareness campaign twice annually to educate  the community about CML  to gain its support
Make the drug affordablefor poor patients Cancer society link and bank account for donations on CML Egypt website Marathon Raise money to  provide drugs for  poor patients  Get the drug 4 timed and the 5th time  for free to support  patient’s compliance
Action plan
Action plan (cont.)
Detailed Promotion Plan Over the 5 years:  - Advertise in medical magazines  - Detailing aids worth 50,000 EP/ year  as flyers, brochures and posters containing info on Pluto’s efficacy, side effects, Drug interactions, contraindications & pharmacokinetics.  -7% discount to institutions and wholesalers. -Flyers & medical representatitives to 30 health insurance companies & 3 large wholesalers.
Detailed Promotion Plan
Financial plan Year 1: Sales:  320 x 0.3 x 1500 x 12= 1 728 000 LE FF: 2 Medical Representatives (60, 000 LE) + District              Manager (50, 000 LE) = 110, 000 LE Promotion: ,[object Object]
Abroad Meeting (20, 000 x 3 = 60, 000 LE)
Detailing  Aid (50, 000 LE)
Gifts ( 20, 000 LE)
Medical Magazines (10, 000 LE),[object Object]
Financial Plan
Financial Plan: Sales Sales Year

Contenu connexe

Tendances

Healthcare Cost Saving Opportunities | MD Buyline
Healthcare Cost Saving Opportunities | MD BuylineHealthcare Cost Saving Opportunities | MD Buyline
Healthcare Cost Saving Opportunities | MD BuylineMD Buyline
 
Simon Moody: Challenges of risk adjustment in health
Simon Moody: Challenges of risk adjustment in healthSimon Moody: Challenges of risk adjustment in health
Simon Moody: Challenges of risk adjustment in healthNuffield Trust
 
Medicare physicians-new-fee-schedule-2016
Medicare physicians-new-fee-schedule-2016Medicare physicians-new-fee-schedule-2016
Medicare physicians-new-fee-schedule-2016Andersen Keen
 
Journal Club Presentation Mb Rb
Journal Club Presentation Mb RbJournal Club Presentation Mb Rb
Journal Club Presentation Mb Rbmboufaida
 
2018 Healthcare Outlook #5
2018 Healthcare Outlook #52018 Healthcare Outlook #5
2018 Healthcare Outlook #5Guidehouse
 
The pharmaceutical business...
The pharmaceutical business...The pharmaceutical business...
The pharmaceutical business...hrvoboril
 
Understanding the evolving healthcare ecosystem -- Aimia -- 052714
Understanding the evolving healthcare ecosystem -- Aimia -- 052714Understanding the evolving healthcare ecosystem -- Aimia -- 052714
Understanding the evolving healthcare ecosystem -- Aimia -- 052714David Nickelson, PsyD, JD
 
Hh Marketing
Hh MarketingHh Marketing
Hh Marketingnha8570
 
Impact of Mismatched Patient Records Inforgraphic
Impact of Mismatched Patient Records InforgraphicImpact of Mismatched Patient Records Inforgraphic
Impact of Mismatched Patient Records InforgraphicTodd Winey
 
Untapped potential for sustainable competitive differentiation of pharma comp...
Untapped potential for sustainable competitive differentiation of pharma comp...Untapped potential for sustainable competitive differentiation of pharma comp...
Untapped potential for sustainable competitive differentiation of pharma comp...Philippe Barzin
 
2018 Healthcare Outlook #1
2018 Healthcare Outlook #12018 Healthcare Outlook #1
2018 Healthcare Outlook #1Guidehouse
 
2018 Healthcare Outlook #3
2018 Healthcare Outlook #32018 Healthcare Outlook #3
2018 Healthcare Outlook #3Guidehouse
 
Real world suggestions
Real world suggestionsReal world suggestions
Real world suggestionsMelissa Paige
 
Value based purchasing prebacked
Value based purchasing prebackedValue based purchasing prebacked
Value based purchasing prebackedDavid Parpart, D.C.
 
A peak into the future healthcare systems and hospitals by Steven Lash
A peak into the future healthcare systems and hospitals by Steven LashA peak into the future healthcare systems and hospitals by Steven Lash
A peak into the future healthcare systems and hospitals by Steven LashSteven Lash
 
Skilled Nursing Facility Reimbursements
Skilled Nursing Facility ReimbursementsSkilled Nursing Facility Reimbursements
Skilled Nursing Facility ReimbursementsAlanna Moriarty
 
Economic Credentialing - Abuse of Peer Review?
Economic Credentialing - Abuse of Peer Review?Economic Credentialing - Abuse of Peer Review?
Economic Credentialing - Abuse of Peer Review?OnlineCompliance Panel
 

Tendances (20)

Healthcare Cost Saving Opportunities | MD Buyline
Healthcare Cost Saving Opportunities | MD BuylineHealthcare Cost Saving Opportunities | MD Buyline
Healthcare Cost Saving Opportunities | MD Buyline
 
App - Final Project
App - Final ProjectApp - Final Project
App - Final Project
 
Simon Moody: Challenges of risk adjustment in health
Simon Moody: Challenges of risk adjustment in healthSimon Moody: Challenges of risk adjustment in health
Simon Moody: Challenges of risk adjustment in health
 
Medicare physicians-new-fee-schedule-2016
Medicare physicians-new-fee-schedule-2016Medicare physicians-new-fee-schedule-2016
Medicare physicians-new-fee-schedule-2016
 
Journal Club Presentation Mb Rb
Journal Club Presentation Mb RbJournal Club Presentation Mb Rb
Journal Club Presentation Mb Rb
 
2018 Healthcare Outlook #5
2018 Healthcare Outlook #52018 Healthcare Outlook #5
2018 Healthcare Outlook #5
 
The pharmaceutical business...
The pharmaceutical business...The pharmaceutical business...
The pharmaceutical business...
 
Understanding the evolving healthcare ecosystem -- Aimia -- 052714
Understanding the evolving healthcare ecosystem -- Aimia -- 052714Understanding the evolving healthcare ecosystem -- Aimia -- 052714
Understanding the evolving healthcare ecosystem -- Aimia -- 052714
 
Hh Marketing
Hh MarketingHh Marketing
Hh Marketing
 
Impact of Mismatched Patient Records Inforgraphic
Impact of Mismatched Patient Records InforgraphicImpact of Mismatched Patient Records Inforgraphic
Impact of Mismatched Patient Records Inforgraphic
 
Untapped potential for sustainable competitive differentiation of pharma comp...
Untapped potential for sustainable competitive differentiation of pharma comp...Untapped potential for sustainable competitive differentiation of pharma comp...
Untapped potential for sustainable competitive differentiation of pharma comp...
 
2018 Healthcare Outlook #1
2018 Healthcare Outlook #12018 Healthcare Outlook #1
2018 Healthcare Outlook #1
 
2018 Healthcare Outlook #3
2018 Healthcare Outlook #32018 Healthcare Outlook #3
2018 Healthcare Outlook #3
 
Real world suggestions
Real world suggestionsReal world suggestions
Real world suggestions
 
Value based purchasing prebacked
Value based purchasing prebackedValue based purchasing prebacked
Value based purchasing prebacked
 
A peak into the future healthcare systems and hospitals by Steven Lash
A peak into the future healthcare systems and hospitals by Steven LashA peak into the future healthcare systems and hospitals by Steven Lash
A peak into the future healthcare systems and hospitals by Steven Lash
 
Pmd bop 4-17-13
Pmd   bop 4-17-13Pmd   bop 4-17-13
Pmd bop 4-17-13
 
Mhe infographic-other-color
Mhe infographic-other-colorMhe infographic-other-color
Mhe infographic-other-color
 
Skilled Nursing Facility Reimbursements
Skilled Nursing Facility ReimbursementsSkilled Nursing Facility Reimbursements
Skilled Nursing Facility Reimbursements
 
Economic Credentialing - Abuse of Peer Review?
Economic Credentialing - Abuse of Peer Review?Economic Credentialing - Abuse of Peer Review?
Economic Credentialing - Abuse of Peer Review?
 

Similaire à Team 2

Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryEngr. Carlo Senica, MBA, CPSM
 
Marketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA ProgramMarketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA Programjreidglass1
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond AndersonStarttech Ventures
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxodiliagilby
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxavaforman16457
 
Hope soars as first malaria vaccine clears final hurdle
Hope soars as first malaria vaccine clears final hurdleHope soars as first malaria vaccine clears final hurdle
Hope soars as first malaria vaccine clears final hurdleOther Mother
 
Bellus corporate presentation january 2014 v final
Bellus corporate presentation january 2014 v finalBellus corporate presentation january 2014 v final
Bellus corporate presentation january 2014 v finalBellusHealth
 
Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09thess1121
 
06 Solaiman Sittie Fayha_10 Step Marketing Plan
06 Solaiman Sittie Fayha_10 Step Marketing Plan06 Solaiman Sittie Fayha_10 Step Marketing Plan
06 Solaiman Sittie Fayha_10 Step Marketing PlanSittie Fayha Solaiman
 
New Health Report 2012 - Media Briefing Deck
New Health Report 2012 - Media Briefing Deck New Health Report 2012 - Media Briefing Deck
New Health Report 2012 - Media Briefing Deck Quintiles
 
DEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORT
DEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORTDEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORT
DEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORTiData Insights
 
Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Mohammed Alshakka
 
2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience GSW
 
Zero Sum Game article
Zero Sum Game articleZero Sum Game article
Zero Sum Game articlePamela Chiesi
 

Similaire à Team 2 (20)

Team 3
Team 3Team 3
Team 3
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical Industry
 
Marketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA ProgramMarketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA Program
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docx
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docx
 
Hope soars as first malaria vaccine clears final hurdle
Hope soars as first malaria vaccine clears final hurdleHope soars as first malaria vaccine clears final hurdle
Hope soars as first malaria vaccine clears final hurdle
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
 
Bellus corporate presentation january 2014 v final
Bellus corporate presentation january 2014 v finalBellus corporate presentation january 2014 v final
Bellus corporate presentation january 2014 v final
 
Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09
 
06 Solaiman Sittie Fayha_10 Step Marketing Plan
06 Solaiman Sittie Fayha_10 Step Marketing Plan06 Solaiman Sittie Fayha_10 Step Marketing Plan
06 Solaiman Sittie Fayha_10 Step Marketing Plan
 
MBA Project
MBA ProjectMBA Project
MBA Project
 
MMV Annual_Report_2015, My Interview
MMV Annual_Report_2015, My InterviewMMV Annual_Report_2015, My Interview
MMV Annual_Report_2015, My Interview
 
New Health Report 2012 - Media Briefing Deck
New Health Report 2012 - Media Briefing Deck New Health Report 2012 - Media Briefing Deck
New Health Report 2012 - Media Briefing Deck
 
DEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORT
DEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORTDEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORT
DEAL ANALYSIS OF TOP 10 ONCOLOGY COMPANIES: MONTHLY REPORT
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
 
Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...
 
Cydy investor presentation_jan-2020
Cydy investor presentation_jan-2020Cydy investor presentation_jan-2020
Cydy investor presentation_jan-2020
 
2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience
 
Zero Sum Game article
Zero Sum Game articleZero Sum Game article
Zero Sum Game article
 

Plus de Mariam Reyad

Phaeocystis-antarctica-transcriptomics-AM
Phaeocystis-antarctica-transcriptomics-AMPhaeocystis-antarctica-transcriptomics-AM
Phaeocystis-antarctica-transcriptomics-AMMariam Reyad
 
Mrr cmb journal_club_20111115
Mrr cmb journal_club_20111115Mrr cmb journal_club_20111115
Mrr cmb journal_club_20111115Mariam Reyad
 
Mrr 05152011 pmdb_proposal
Mrr 05152011 pmdb_proposalMrr 05152011 pmdb_proposal
Mrr 05152011 pmdb_proposalMariam Reyad
 
فيروس ملتحمة العين
فيروس ملتحمة العينفيروس ملتحمة العين
فيروس ملتحمة العينMariam Reyad
 
Forex-ITI-Intake31
Forex-ITI-Intake31Forex-ITI-Intake31
Forex-ITI-Intake31Mariam Reyad
 
Nardeen nagy the play_2010
Nardeen nagy the play_2010Nardeen nagy the play_2010
Nardeen nagy the play_2010Mariam Reyad
 
Mrr last judge-2010
Mrr last judge-2010Mrr last judge-2010
Mrr last judge-2010Mariam Reyad
 
MRR_Harris_JC_20100217
MRR_Harris_JC_20100217MRR_Harris_JC_20100217
MRR_Harris_JC_20100217Mariam Reyad
 

Plus de Mariam Reyad (13)

Phaeocystis-antarctica-transcriptomics-AM
Phaeocystis-antarctica-transcriptomics-AMPhaeocystis-antarctica-transcriptomics-AM
Phaeocystis-antarctica-transcriptomics-AM
 
Mrr cmb journal_club_20111115
Mrr cmb journal_club_20111115Mrr cmb journal_club_20111115
Mrr cmb journal_club_20111115
 
Mrr iti phar_mu
Mrr iti phar_muMrr iti phar_mu
Mrr iti phar_mu
 
Mrr iti pm_poster
Mrr iti pm_posterMrr iti pm_poster
Mrr iti pm_poster
 
Mrr 05152011 pmdb_proposal
Mrr 05152011 pmdb_proposalMrr 05152011 pmdb_proposal
Mrr 05152011 pmdb_proposal
 
فيروس ملتحمة العين
فيروس ملتحمة العينفيروس ملتحمة العين
فيروس ملتحمة العين
 
Forex-ITI-Intake31
Forex-ITI-Intake31Forex-ITI-Intake31
Forex-ITI-Intake31
 
Team 4
Team 4Team 4
Team 4
 
Team 5
Team 5Team 5
Team 5
 
Team1
Team1Team1
Team1
 
Nardeen nagy the play_2010
Nardeen nagy the play_2010Nardeen nagy the play_2010
Nardeen nagy the play_2010
 
Mrr last judge-2010
Mrr last judge-2010Mrr last judge-2010
Mrr last judge-2010
 
MRR_Harris_JC_20100217
MRR_Harris_JC_20100217MRR_Harris_JC_20100217
MRR_Harris_JC_20100217
 

Dernier

SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptraviapr7
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 

Dernier (20)

SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.ppt
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 

Team 2

Notes de l'éditeur

  1. As inspired by novartis mission stat
  2. 320 patientsX75%X 1500X 12 months
  3. 6) not only for the profit 7) options of resistant and intolerable CML
  4. in private clinics & Cancer institutes Cancer institute, Nasser institute4.Ministry of health, army forces